Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Johnson

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
Angewandte Chemie (International Ed. in English)|January 9, 2013
Size-dependent structural distortions in one-dimensional nanostructuresMichael D Anderson, Colby L Heideman, Qiyin Lin, et al.
Blood|May 24, 2013
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myelomaMartin F Kaiser, David C Johnson, Ping Wu, et al.
Urology|January 16, 2017
Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral CenterClayton W Commander, David C Johnson, Mathew C Raynor, et al.
Haematologica|July 28, 2011
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patientsSophie L Corthals, Rowan Kuiper, David C Johnson, et al.
Oncology Nursing Forum|March 26, 2015
Improving couples' quality of life through a Web-based prostate cancer education interventionLixin Song, Christine Rini, Allison M Deal, et al.
Urologic Oncology|September 21, 2019
Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factorsAydin Pooli, Amirali Salmasi, David C Johnson, et al.
World Journal of Urology|September 30, 2018
Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelinesAlexander Upfill-Brown, Andrew T Lenis, Izak Faiena, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Urologic Oncology|November 13, 2017
Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinomaAndrew T Lenis, Amirali H Salmasi, Nicholas M Donin, et al.
European Urology Oncology|September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center StudyAndrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Angewandte Chemie (International Ed. in English)|January 9, 2013
Size-dependent structural distortions in one-dimensional nanostructuresMichael D Anderson, Colby L Heideman, Qiyin Lin, et al.
Blood|May 24, 2013
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myelomaMartin F Kaiser, David C Johnson, Ping Wu, et al.
Urology|January 16, 2017
Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral CenterClayton W Commander, David C Johnson, Mathew C Raynor, et al.
Haematologica|July 28, 2011
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patientsSophie L Corthals, Rowan Kuiper, David C Johnson, et al.
Oncology Nursing Forum|March 26, 2015
Improving couples' quality of life through a Web-based prostate cancer education interventionLixin Song, Christine Rini, Allison M Deal, et al.
Urologic Oncology|September 21, 2019
Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factorsAydin Pooli, Amirali Salmasi, David C Johnson, et al.
World Journal of Urology|September 30, 2018
Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelinesAlexander Upfill-Brown, Andrew T Lenis, Izak Faiena, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Urologic Oncology|November 13, 2017
Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinomaAndrew T Lenis, Amirali H Salmasi, Nicholas M Donin, et al.
European Urology Oncology|September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center StudyAndrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
Pageof 25